The hottest Hormone Therapy Substack posts right now

And their main takeaways
Category
Top Health & Wellness Topics
The Vajenda 3812 implied HN points 17 Oct 23
  1. Suzanne Somers promoted unsafe compounded hormones as better for menopause under the guise of female empowerment.
  2. Somers popularized the terms 'bioidentical hormones' through media coverage and celebrity endorsement.
  3. Compounded hormones lack safety data and precision dosing compared to pharmaceutical products, making them less safe.
The Vajenda 3223 implied HN points 03 Oct 23
  1. Statins are effective for women in reducing cardiovascular disease risk.
  2. Statin side effects are not as common as believed; most often, it's due to the 'nocebo effect'.
  3. Regular ovarian cancer screening methods like ultrasounds and CA-125 tests are not very effective; focus should be on preventive strategies like oral contraception.
The Vajenda 2476 implied HN points 19 Jun 23
  1. Menopausal hormone therapy has both benefits and risks, and it's important for individuals to have accurate information to make informed decisions.
  2. Prioritize exercise, a healthy diet, and not smoking for overall health during menopause.
  3. Menopausal hormone therapy involves prescribing estrogen or progesterone to alleviate symptoms, and progestogen is essential for those taking estrogen to protect against uterine issues.
The Vajenda 1139 implied HN points 07 Feb 24
  1. Reproductive hormones can have different effects on women, such as premenstrual syndrome and postpartum depression.
  2. Progesterone/progestins in menopausal hormone therapy can impact mood and may have complex interactions in the brain.
  3. Options to consider if progesterone/progestins negatively affect quality of life include switching dosage or trying alternative medications.
Get a weekly roundup of the best Substack posts, by hacker news affinity:
Ladyparts 1198 implied HN points 30 Nov 23
  1. Menopausal hormone therapy prescribing was affected by misinterpreted data from the Women's Health Initiative, impacting a generation of women
  2. The review in Menopause, The Journal of the Menopause Society sheds light on the critical misinterpretation that nearly halted hormone treatment for menopausal women in the U.S.
  3. The article highlights how the WHI data misinterpretation led to a significant impact on hormone therapy for menopausal women in the United States
Ladyparts 1098 implied HN points 02 May 23
  1. Menopausal women face economic challenges due to the impact of menopause on their working time and the high costs of healthcare, including expensive medications like estrogen and migraine treatments.
  2. Medical research is shedding light on the unique risks and ecosystem of the menopausal bladder, urging doctors to be more diligent and thoughtful in treating post-menopausal patients with recurring UTIs.
  3. Women in menopause often experience challenges in healthcare settings, facing issues like doctor dismissiveness, lack of training in dealing with menopause-related conditions, and the importance of finding doctors who listen and provide appropriate care.
Are You Okay? 499 implied HN points 21 Jul 23
  1. Hormone replacement therapy (HRT) can be considered before menopause if a woman is experiencing menopausal symptoms and low estrogen is identified as the cause.
  2. Menopausal hormone therapy (MHT) is generally safe for healthy women when started within 10 years of menopause, and the benefits usually outweigh the risks.
  3. Continuing hormone replacement therapy after the age of 65 should be assessed based on individual health risks and conditions to determine if the benefits still outweigh the potential downsides.
Ladyparts 619 implied HN points 04 Apr 23
  1. An earlier onset of menopause and a later initiation of hormone therapy could lead to an increase in the tau tangles of Alzheimer's.
  2. Females are more likely to be affected by Alzheimer's, with two out of every three cases involving a female.
  3. Dr. Lisa Mosconi, a neurologist, highlighted the potential impact of a drop in estrogen at menopause on the female body in relation to Alzheimer's.
Are You Okay? 199 implied HN points 04 Aug 23
  1. Testosterone therapy for low sexual desire in women is not FDA-approved and is sometimes used off-label. It needs to be approached with caution due to potential risks and lack of long-term safety data.
  2. Low sex drive in a relationship doesn't always need fixing; some couples are content without sexual intimacy. Understanding and respecting each other's needs and choices is important.
  3. It's crucial to consider a variety of potential factors, from hormones to psychological aspects, when addressing low sexual desire. Consulting with a healthcare provider before starting any treatment is essential.
Ladyparts 279 implied HN points 11 Jul 22
  1. Hormone therapy is considered the most effective treatment for vasomotor symptoms and the genitourinary syndrome of menopause.
  2. There was a misunderstanding about hormone therapy due to misinformation from the Women's Health Initiative study in 2002.
  3. Subsequent studies have shown that hormone therapy can have a beneficial risk-to-benefit ratio for younger women and those close to menopause.
Are You Okay? 119 implied HN points 12 Sep 22
  1. Menopause hormone therapy can be safe and beneficial when prescribed appropriately, considering individual risks and benefits.
  2. Estrogen doesn't cause breast cancer for the majority of women; the benefits of hormone therapy often outweigh the risks.
  3. Women going through menopause should have open conversations with healthcare providers to make informed decisions about hormone therapy.
Are You Okay? 19 implied HN points 13 Feb 23
  1. Lucy McBride is hosting Zoom hangouts for paid subscribers to discuss health topics like Menopause & Women's Health: Risks & Benefits of Hormone Therapy.
  2. The upcoming session focuses on data and decision-making regarding hormone therapy, with an opportunity for subscribers to watch a recording if they can't attend live.
  3. Subscribers can access exclusive content and engage in discussions by subscribing to Lucy McBride's newsletter.